PCR104 Improvements in Health Utility Scores after Administration of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract that commonly result in iron deficiency anemia (IDA) due to impaired iron absorption and chronic blood loss. Patients with IBD experience reduced health-related quality of life, with fatigue playing a key role. The aim of the present analysis was to calculate health state utility values (HSUVs) from a recent randomized controlled trial (RCT) of intravenous iron in the treatment of patients with IBD and IDA.